These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 164568)
1. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma. Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. Bast RC; Zbar B; Mackaness GB; Rapp HJ J Natl Cancer Inst; 1975 Mar; 54(3):749-56. PubMed ID: 804566 [TBL] [Abstract][Full Text] [Related]
3. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus. Minden P; McClatchy JK; Brunda MJ J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295 [TBL] [Abstract][Full Text] [Related]
4. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG. Harmel RP; Zbar B; Rapp HJ J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria. Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802 [TBL] [Abstract][Full Text] [Related]
6. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs. McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361 [TBL] [Abstract][Full Text] [Related]
7. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524 [No Abstract] [Full Text] [Related]
8. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG. Kataoka T; Tokunaga T; Murohashi T J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348 [TBL] [Abstract][Full Text] [Related]
9. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs. Fidler IJ; Kataoka T; Hanna MG Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147 [No Abstract] [Full Text] [Related]
11. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases. Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146 [TBL] [Abstract][Full Text] [Related]
12. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin. Minden P; Mathews HL Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine. Hanna MG; Peters LC Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374 [TBL] [Abstract][Full Text] [Related]
14. Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma. Chen Y; Yang D; Li S; Gao Y; Jiang R; Deng L; Frankel FR; Sun B Oncogene; 2012 Apr; 31(17):2140-52. PubMed ID: 21927025 [TBL] [Abstract][Full Text] [Related]
15. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells. Nagai A; Zbar B; Terata N; Hovis J Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216 [TBL] [Abstract][Full Text] [Related]
17. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine. Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776 [TBL] [Abstract][Full Text] [Related]
18. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity. Youdim Cancer Res; 1977 Apr; 37(4):991-6. PubMed ID: 403003 [TBL] [Abstract][Full Text] [Related]
19. Attenuated Listeria infection activates natural killer cell cytotoxicity to regress melanoma growth in vivo. Shen H; Kanoh M; Maruyama S; Matsumoto A; Zhang W; Asano Y Microbiol Immunol; 2008 Feb; 52(2):107-17. PubMed ID: 18380808 [TBL] [Abstract][Full Text] [Related]
20. Abrogation of tumor rejection by trypan blue. Kreider JW; Bartlett GL; DeFreitas E Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]